{"cdcTestId":"2022-0073","testcaseName":"Dose # 4 PCV15 at 1 year.  Series complete. ","vaccineGroup":"PCV","evaluationTestType":"Age: At Minimum","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2021-10-19T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2021-12-19T00:00:00","vaccineName":"VAXNEUVANCE","cvx":"215","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-02-19T00:00:00","vaccineName":"VAXNEUVANCE","cvx":"215","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-04-19T00:00:00","vaccineName":"VAXNEUVANCE","cvx":"215","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"VAXNEUVANCE","cvx":"215","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2021-12-19T00:00:00","vaccineName":"VAXNEUVANCE","cvx":"215","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-02-19T00:00:00","vaccineName":"VAXNEUVANCE","cvx":"215","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-04-19T00:00:00","vaccineName":"VAXNEUVANCE","cvx":"215","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"VAXNEUVANCE","cvx":"215","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2022-09-15T09:25:58.753","generalDescription":"This test case describes when dose #4 of the PCV15 vaccine is administered at age 12 months that the dose is considered to be valid.  The series is complete.","changedInVersion":"4.27","reasonForChange":""}